Norcaesalpin D - Compound Card

Norcaesalpin D

Select a section from the left sidebar

Norcaesalpin D

Structure
Zoomed Structure
  • Family: Plantae - Caesalpiniaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Norcassane Furanoditerpene
Canonical Smiles CC(=O)O[C@H]1[C@@H](OC(=O)C)CC([C@]2([C@@]1(C)[C@H]1C=C3OC(=O)C=C3[C@H]([C@@H]1CC2)C)O)(C)C
InChI InChI=1S/C24H32O7/c1-12-15-7-8-24(28)22(4,5)11-19(29-13(2)25)21(30-14(3)26)23(24,6)17(15)10-18-16(12)9-20(27)31-18/h9-10,12,15,17,19,21,28H,7-8,11H2,1-6H3/t12-,15-,17-,19-,21-,23-,24+/m0/s1
InChIKey PFIWRCVWRGIPSM-YAIDDFKGSA-N
Formula C24H32O7
HBA 7
HBD 1
MW 432.51
Rotatable Bonds 2
TPSA 99.13
LogP 3.06
Number Rings 4
Number Aromatic Rings 0
Heavy Atom Count 31
Formal Charge 0
Fraction CSP3 0.71
Exact Mass 432.21
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Caesalpinia bonducella Caesalpiniaceae Plantae 191881

Showing of synonyms

  • Nondo RS, Moshi MJ, et al. (2017). Anti-plasmodial activity of Norcaesalpin D and extracts of four medicinal plants used traditionally for treatment of malaria. BMC Complementary and Alternative Medicine,2017,17(1),167. [View] [PubMed]
Pubchem: 102292463

No compound-protein relationship available.

Structure

SMILES: C1C(=O)OC(C=12)=CC3C4C(CCC3C2)CCCC4

Level: 0

Mol. Weight: 432.51 g/mol

Antimalarial

Absorption

Caco-2 (logPapp)
-4.47
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.76
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.61

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.8
Plasma Protein Binding
69.85
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
10.59
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.11
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.23
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
6.32
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-31.44
Rat (Acute)
2.54
Rat (Chronic Oral)
1.95
Fathead Minnow
3.92
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
414.63
Hydration Free Energy
-3.64
Log(D) at pH=7.4
2.55
Log(P)
2.45
Log S
-4.68
Log(Vapor Pressure)
-7.63
Melting Point
179.24
pKa Acid
7.93
pKa Basic
4.4
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Ferrochelatase, mitochondrial P22830 HEMH_HUMAN Homo sapiens 3 0.7208
Ferrochelatase, mitochondrial P22830 HEMH_HUMAN Homo sapiens 3 0.7208

Download SDF